1. Home
  2. AROW vs REPL Comparison

AROW vs REPL Comparison

Compare AROW & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AROW
  • REPL
  • Stock Information
  • Founded
  • AROW 1851
  • REPL 2015
  • Country
  • AROW United States
  • REPL United States
  • Employees
  • AROW N/A
  • REPL N/A
  • Industry
  • AROW Major Banks
  • REPL Biotechnology: Pharmaceutical Preparations
  • Sector
  • AROW Finance
  • REPL Health Care
  • Exchange
  • AROW Nasdaq
  • REPL Nasdaq
  • Market Cap
  • AROW 487.0M
  • REPL 547.0M
  • IPO Year
  • AROW N/A
  • REPL 2018
  • Fundamental
  • Price
  • AROW $27.70
  • REPL $4.68
  • Analyst Decision
  • AROW Hold
  • REPL Hold
  • Analyst Count
  • AROW 1
  • REPL 9
  • Target Price
  • AROW $28.00
  • REPL $6.67
  • AVG Volume (30 Days)
  • AROW 40.0K
  • REPL 4.7M
  • Earning Date
  • AROW 10-30-2025
  • REPL 11-11-2025
  • Dividend Yield
  • AROW 4.21%
  • REPL N/A
  • EPS Growth
  • AROW N/A
  • REPL N/A
  • EPS
  • AROW 1.83
  • REPL N/A
  • Revenue
  • AROW $140,422,000.00
  • REPL N/A
  • Revenue This Year
  • AROW $22.74
  • REPL N/A
  • Revenue Next Year
  • AROW $6.91
  • REPL N/A
  • P/E Ratio
  • AROW $15.06
  • REPL N/A
  • Revenue Growth
  • AROW 5.15
  • REPL N/A
  • 52 Week Low
  • AROW $22.72
  • REPL $2.68
  • 52 Week High
  • AROW $34.63
  • REPL $17.00
  • Technical
  • Relative Strength Index (RSI)
  • AROW 38.48
  • REPL 47.44
  • Support Level
  • AROW $27.11
  • REPL $3.12
  • Resistance Level
  • AROW $29.89
  • REPL $4.46
  • Average True Range (ATR)
  • AROW 0.69
  • REPL 0.41
  • MACD
  • AROW -0.22
  • REPL 0.09
  • Stochastic Oscillator
  • AROW 20.63
  • REPL 55.52

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: